Multi-omics in mesial temporal lobe epilepsy with hippocampal sclerosis: Clues into the underlying mechanisms leading to disease
Related Experiment Video
Updated: Nov 12, 2025
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Estela M Bruxel1, Danielle C F Bruno1, Amanda M do Canto1
1Departments of Medical Genetics and Genomic Medicine, School of Medical Sciences, University of Campinas (UNICAMP), and the Brazilian Institute of Neuroscience and Neurotechnology, Campinas, SP, Brazil.
Abstract:
Mesial temporal lobe epilepsy (MTLE) is one of the most common types of focal epilepsy in the adult population. MTLE is frequently associated with a specific histopathological lesion in the medial temporal structures, namely hippocampal sclerosis (HS). A significant proportion of patients with MTLE+HS have severe epilepsy, which is often resistant to clinical treatment. For these patients, surgical resection of the epileptogenic lesion can be performed. Our understanding of the underlying mechanisms leading to MTLE+HS has improved significantly over the past few decades. In this review, we aim to present and discuss the most recent findings regarding the genetic determinants of MTLE+HS. Furthermore, we will address studies about transcriptomics, proteomics, metabolomics, and epigenomic signatures of the tissue that is surgically removed from patients with refractory MTLE+HS and animal models of the disorder. We expect to provide an overview and a critical discussion of the findings, limitations, new approaches, and future directions for multi-omics studies in MTLE+HS.
Insights
Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE+HS) is a common, often treatment-resistant epilepsy. This review explores genetic factors and multi-omics data from patient tissues and animal models to understand MTLE+HS mechanisms.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE+HS) is a prevalent focal epilepsy in adults.
- MTLE+HS often presents as severe, intractable epilepsy requiring surgical intervention.
- Recent advancements have deepened our understanding of the molecular underpinnings of MTLE+HS.
Purpose of the Study:
- To review current genetic findings related to MTLE+HS.
- To discuss multi-omics (transcriptomics, proteomics, metabolomics, epigenomics) data from MTLE+HS tissues and models.
- To critically evaluate limitations and future directions for multi-omics research in MTLE+HS.
Main Methods:
- Literature review of genetic studies in MTLE+HS.
- Analysis of multi-omics data from surgically resected MTLE+HS tissues.
- Examination of findings from relevant animal models of MTLE+HS.
Main Results:
- Recent research has identified genetic determinants contributing to MTLE+HS.
- Multi-omics analyses reveal complex molecular signatures in affected tissues.
- These signatures offer insights into disease mechanisms and potential therapeutic targets.
Conclusions:
- Understanding the genetic and molecular basis of MTLE+HS is crucial for developing effective treatments.
- Multi-omics approaches provide a comprehensive view of disease pathology.
- Further research is needed to translate these findings into clinical applications for refractory epilepsy.
